NO991733L - FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering - Google Patents

FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering

Info

Publication number
NO991733L
NO991733L NO991733A NO991733A NO991733L NO 991733 L NO991733 L NO 991733L NO 991733 A NO991733 A NO 991733A NO 991733 A NO991733 A NO 991733A NO 991733 L NO991733 L NO 991733L
Authority
NO
Norway
Prior art keywords
preparation
igm
intravenous administration
immunoglobulin
protease
Prior art date
Application number
NO991733A
Other languages
English (en)
Norwegian (no)
Other versions
NO991733D0 (no
Inventor
Markus Rentsch
Original Assignee
Rotkreuzstiftung Zentrallab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rotkreuzstiftung Zentrallab filed Critical Rotkreuzstiftung Zentrallab
Publication of NO991733D0 publication Critical patent/NO991733D0/no
Publication of NO991733L publication Critical patent/NO991733L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO991733A 1996-10-14 1999-04-13 FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering NO991733L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP96810690A EP0835880A1 (de) 1996-10-14 1996-10-14 Verfahren zur Herstellung eines IgM Präparates für die intravenöse Applikation
PCT/CH1997/000388 WO1998016558A1 (de) 1996-10-14 1997-10-14 VERFAHREN ZUR HERSTELLUNG EINES IgM-PRÄPARATES FÜR DIE INTRAVENÖSE APPLIKATION

Publications (2)

Publication Number Publication Date
NO991733D0 NO991733D0 (no) 1999-04-13
NO991733L true NO991733L (no) 1999-06-11

Family

ID=8225725

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991733A NO991733L (no) 1996-10-14 1999-04-13 FremgangsmÕte for fremstilling av et IgM-preparat for intraven°s administrering

Country Status (19)

Country Link
US (1) US6136312A (cs)
EP (1) EP0835880A1 (cs)
JP (1) JP2001504092A (cs)
KR (1) KR20000048826A (cs)
CN (1) CN1233258A (cs)
AU (1) AU725134B2 (cs)
BR (1) BR9712306A (cs)
CA (1) CA2266848A1 (cs)
CZ (1) CZ125599A3 (cs)
HU (1) HUP0001069A3 (cs)
ID (1) ID21364A (cs)
IL (1) IL129383A0 (cs)
NO (1) NO991733L (cs)
NZ (1) NZ334885A (cs)
PL (1) PL332774A1 (cs)
RU (1) RU2191032C2 (cs)
SI (1) SI9720063A (cs)
SK (1) SK46699A3 (cs)
WO (1) WO1998016558A1 (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8142780B2 (en) * 1998-08-20 2012-03-27 Strox Biopharmaceuticals, Llc Anti-bacterial antibodies
EP2204190A1 (en) 2003-07-15 2010-07-07 Chugai Seiyaku Kabushiki Kaisha IgM production by transformed cells and methods for quantifying said IgM production
JP4762717B2 (ja) 2003-10-09 2011-08-31 中外製薬株式会社 ＩｇＭ高濃度安定化溶液
JP4671864B2 (ja) 2003-10-09 2011-04-20 中外製薬株式会社 タンパク質溶液の安定化方法
US8852585B2 (en) * 2006-01-30 2014-10-07 Grifols Therapeutics Inc. Method of treatment and prophylaxis of diseases related to amyloid deposition using IgM
FR2899111B1 (fr) * 2006-03-31 2010-09-03 Lab Francais Du Fractionnement Concentre d'immunoglobulines specifiques du chikungunya en tant que medicament.
AU2009246510B2 (en) * 2008-05-12 2014-02-13 Strox Biopharmaceuticals, Llc Staphylococcus aureus-specific antibody preparations
CN101721633B (zh) * 2008-10-16 2011-12-21 岳道友 一种促进动物生长的中草药
GB201006753D0 (en) * 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
RU2470664C2 (ru) * 2010-08-23 2012-12-27 Андрей Германович Лютов Способ получения иммуноглобулина для внутривенного введения, обогащенного иммуноглобулином м, и препарат, полученный этим способом
NZ726911A (en) 2014-06-03 2023-01-27 Xbiotech Inc Compositions and methods for treating and preventing staphylococcus aureus infections
CN115768789A (zh) * 2020-07-10 2023-03-07 基立福环球运营有限公司 用于获得包含人血浆来源的免疫球蛋白m的组合物的方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4075193A (en) * 1976-11-26 1978-02-21 Parke, Davis & Company Process for producing intravenous immune globulin
DE2901822A1 (de) * 1979-01-18 1980-07-31 Biotest Serum Institut Gmbh Verfahren zur herstellung einer fuer die intravenoese applikation geeigneten immunglobulinloesung, die igm in ankonzentrierter form enthaelt
US4371520A (en) * 1981-10-28 1983-02-01 The Green Cross Corporation Process for preparing immunoglobulin suitable for intravenous injection
AT383739B (de) * 1983-03-16 1987-08-10 Immuno Ag Verfahren zur inaktivierung von unvertraeglichkeitsreaktionen verursachenden substanzen in immunglobulinhaeltigen blutfraktionen
IT1186766B (it) * 1985-11-08 1987-12-16 Sclavo Spa Metodo per la preparazione di immunoglobuline per uso endovenoso
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
DE3927112C1 (cs) * 1989-08-17 1990-10-25 Biotest Pharma Gmbh, 6072 Dreieich, De
DE3927111C3 (de) * 1989-08-17 1994-09-01 Biotest Pharma Gmbh Verfahren zur Herstellung nicht modifizierter intravenös verabreichbarer IgM- und/oderIgA-haltiger Immunglobulinpräparate

Also Published As

Publication number Publication date
HUP0001069A2 (hu) 2000-10-28
WO1998016558A1 (de) 1998-04-23
HUP0001069A3 (en) 2000-12-28
AU725134B2 (en) 2000-10-05
NO991733D0 (no) 1999-04-13
SI9720063A (sl) 1999-08-31
NZ334885A (en) 2000-09-29
CA2266848A1 (en) 1998-04-23
BR9712306A (pt) 1999-08-31
AU4449597A (en) 1998-05-11
KR20000048826A (ko) 2000-07-25
IL129383A0 (en) 2000-02-17
CN1233258A (zh) 1999-10-27
ID21364A (id) 1999-05-27
PL332774A1 (en) 1999-10-11
SK46699A3 (en) 2000-06-12
EP0835880A1 (de) 1998-04-15
US6136312A (en) 2000-10-24
RU2191032C2 (ru) 2002-10-20
CZ125599A3 (cs) 1999-07-14
JP2001504092A (ja) 2001-03-27

Similar Documents

Publication Publication Date Title
DE69312077D1 (de) Behandlung von autoimmun- und entzundungskrankheiten
DE69532961D1 (de) Verwendung von porphyrine in der behandlung von multiple sklerose
ATE180408T1 (de) Herstellung eines arzneimittels zur behandlung von augenentzündung durch blockierung von zelladhäsionsmolekulen
ATA29495A (de) Zusammensetzung und verfahren zur prävention und behandlung von entzündungen mit immunglobulin a
NZ326555A (en) Inhibitors of interleukin-1beta converting enzyme (ICE)
DE69233012D1 (de) Mit staphylococcus epidermidis assoziierte oberflächenantigene des typs i
DE59105609D1 (de) Verwendung von anti-TNF-Antikörpern als Arzneimittel bei der Behandlung von Ischämien und deren Folgen.
EP0669836A1 (en) THERAPEUTIC APPLICATION OF CHEMICAL AND RADIO-BRANDED ANTIBODIES AGAINST THE RESTRICTED DIFFERENTIATED ANTIGEN OF HUMAN B LYMPHOCYTES FOR THE TREATMENT OF B CELL LYMPHOMA
DE58905514D1 (de) Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen immunoglobulin-Präparates mit hohemIgM-Gehalt.
DK166763C (da) Immunoglobulin-g-holdig fraktion
DK0536182T3 (da) Fremgangsmåde til behandling af alopecia
ATE45961T1 (de) Humanes cytomegalovirus immunserumglobulin mit hohem titer und verfahren zu seiner herstellung.
ATE117900T1 (de) Verfahren zur herstellung nicht modifizierter intravenös verabreichbarer igm- und/oder iga- haltige immunglobulinpräparate.
EG20772A (fr) Associations d'un fongicide a groupe azole avec un insecticide a groupe pyrazole pyrrole ou phenylimidazole
NO890046L (no) Disubstituerte pyridiner.
DE69423577D1 (de) Verwendung von Oenothein B zur Herstellung eines Medikaments zur Behandlung der durch Hyperandrogenität bedingte Störungen.
JPH09124507A5 (cs)
ATE37182T1 (de) Imidazolinone und imidazolidinthione, verfahren zu deren herstellung und verwendung dieser verbindungen als herbizide.
DE68906551D1 (de) Azolsubstituierte cycloalkanol-derivate, verfahren zu deren herstellung und anwendung dieser derivate als fungizide in der landwirtschaft und im gartenbau.
DK0659082T3 (da) Anvendelse af cytochrom P450 inhibitorer til inhibering af metabolismen af nitrogensubstituerede acridiner
NZ334885A (en) Method for producing an igm preparation for intravenous administration
RU96115481A (ru) Способ лечения деформирующего остеоартроза крупных суставов
ATE129712T1 (de) Substituierte pyrido-oxazine.
DE1792555A1 (de) Verfahren zur Herstellung von zur intravenoesen Anwendung geeignetem gamma-Globulin
ATE147269T1 (de) Behandlung von männerunfruchtbarkeit

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application